Your browser doesn't support javascript.
loading
Does a regular nurse-led distress screening and discussion improve quality of life of breast cancer patients treated with curative intent? A randomized controlled trial.
Ploos van Amstel, Floortje K; Peters, Marlies E W J; Donders, Rogier; Schlooz-Vries, Margrethe S; Polman, Lenny J M; van der Graaf, Winette T A; Prins, Judith B; Ottevanger, Petronella B.
Afiliação
  • Ploos van Amstel FK; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Peters MEWJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Donders R; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Schlooz-Vries MS; Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Polman LJM; Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van der Graaf WTA; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Prins JB; Department of Medical Psychology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Ottevanger PB; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Psychooncology ; 29(4): 719-728, 2020 04.
Article em En | MEDLINE | ID: mdl-31876036
ABSTRACT

OBJECTIVE:

We performed a randomized controlled trial (RCT) to investigate whether regular screening with the distress thermometer (DT) by a nurse improved global quality of life (QOL) of patients with breast cancer (BC) treated with curative intent.

METHODS:

BC patients were randomized between regular screening for distress with a nurse-led DT intervention (NDTI) and usual care (UC). Both groups filled out questionnaires at baseline, after each received treatment modality and at follow-up visits up to 2 years. At these points, the intervention group received also the NDTI. The primary outcome was the global QOL of the EORTC QLQ C30 at 2 years after the end of treatment. Analyses were done on an intention-to-treat basis, using analysis of covariance (ANCOVA), generalized least squares, and interaction analyses.

RESULTS:

Of 194 randomized patients, 153 filled out the questionnaires up to 2 years after treatment. There was no significant difference between NDTI and UC in global QOL 2 years after the end of treatment (mean diff. = -1∙273, P = .610; 95% CI [-6.195; 3.649]). Subgroup analysis of patients who received multimodality treatment (surgery, radiotherapy, and chemotherapy, n = 66) showed a significant between-group difference in global QOL over time (mean diff. = -10, P < .001; 95% CI [-14.835; -5.167]) together with other secondary outcome measures in favor of the NDTI.

CONCLUSION:

NDTI did not lead to a significant improvement in global QOL 2 years after the end of treatment for patients with BC. However, the findings indicate that BC patients who received multimodality treatment may benefit from NDTI.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Avaliação de Processos e Resultados em Cuidados de Saúde / Psicoterapia / Qualidade de Vida / Neoplasias da Mama / Angústia Psicológica / Enfermeiras e Enfermeiros Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Qualitative_research / Screening_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Avaliação de Processos e Resultados em Cuidados de Saúde / Psicoterapia / Qualidade de Vida / Neoplasias da Mama / Angústia Psicológica / Enfermeiras e Enfermeiros Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Qualitative_research / Screening_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article